volume 26, issue 2, P309-322 2012
DOI: 10.1016/j.idc.2012.03.005
View full text
|
|
Share
Johan van Griensven, Ermias Diro

Abstract: Visceral leishmaniasis (VL) is a vector-borne parasitic disease targeting tissue macrophages. It is among the most neglected infectious diseases. Classical manifestations of VL include chronic fever, hepatosplenomegaly, and pancytopenia. Most cases can be detected through serologic and molecular testing. Although therapy has historically relied on antimonials, newer therapeutic options include conventional or liposomal amphotericin B, paromomycin and miltefosine. Coinfection with human immunodeficiency virus (…

expand abstract